Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You can be any gender, and any age from newborn to 99 years old
- You (or your child) have been diagnosed with intellectual disability and/or low muscle tone (floppiness) that started in the newborn period, and are being seen at one of the three hospitals involved in this study
- You (or your child's parent or guardian) have been told about the study and have agreed to take part by signing a consent form
- Advanced genetic testing (such as a gene panel, exome, or genome test) has already been done but did not find a clear explanation for the symptoms
- If the symptoms looked like Prader-Willi or Angelman syndrome: a specific chromosome 15 test came back negative
- If the symptoms looked like Fragile X syndrome: a specific test for the FMR1 gene came back negative
- If the symptoms looked like Myotonic Dystrophy type 1: a specific test for the DMPK gene came back negative
- You (or your child) are covered by a French social security or health insurance scheme
Who may not be able to join:
- People who are currently in prison or otherwise deprived of their freedom
- Women who are pregnant or currently breastfeeding
- The person who needs to sign the consent form does not understand French
- People who are under legal guardianship or curatorship (a court-appointed legal protection arrangement)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 33491388499
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patients with identified deleterious variant at RNA level
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.